Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Amicus Therapeutics (FOLD) over the last 16 years, with Dec 2024 value amounting to -$14.0 million.

  • Amicus Therapeutics' Other Working Capital Changes rose 46.90% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year increase of 132.58%. This contributed to the annual value of -$14.0 million for FY2024, which is 273.17% down from last year.
  • According to the latest figures from FY2024, Amicus Therapeutics' Other Working Capital Changes is -$14.0 million, which was down 273.17% from $8.1 million recorded in FY2023.
  • In the past 5 years, Amicus Therapeutics' Other Working Capital Changes registered a high of $8.8 million during FY2020, and its lowest value of -$14.0 million during FY2024.
  • For the 3-year period, Amicus Therapeutics' Other Working Capital Changes averaged around $98,333, with its median value being $6.2 million (2022).
  • In the last 5 years, Amicus Therapeutics' Other Working Capital Changes soared by 166.69% in 2020 and then tumbled by 273.17% in 2024.
  • Over the past 5 years, Amicus Therapeutics' Other Working Capital Changes (Yearly) stood at $8.8 million in 2020, then plummeted by 32.48% to $5.9 million in 2021, then increased by 4.65% to $6.2 million in 2022, then skyrocketed by 30.16% to $8.1 million in 2023, then crashed by 273.17% to -$14.0 million in 2024.